Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID‐19

por Whyte, Claire S., Morrow, Gael B., Mitchell, Joanne L., Chowdary, Pratima, Mutch, Nicola J.
Publicado 2020

COVID‐19: A collision of complement, coagulation and inflammatory pathways

por Chauhan, Anoop J., Wiffen, Laura J., Brown, Thomas P.
Publicado 2020

In vitro hypercoagulability and ongoing in vivo activation of coagulation and fibrinolysis in COVID‐19 patients on anticoagulation

por Blasi, Annabel, von Meijenfeldt, Fien A., Adelmeijer, Jelle, Calvo, Andrea, Ibañez, Cristina, Perdomo, Juan, Reverter, Juan C., Lisman, Ton
Publicado 2020

Incidence of venous thromboembolism in hospitalized patients with COVID‐19

por Middeldorp, Saskia, Coppens, Michiel, van Haaps, Thijs F., Foppen, Merijn, Vlaar, Alexander P., Müller, Marcella C.A., Bouman, Catherine C.S., Beenen, Ludo F.M., Kootte, Ruud S., Heijmans, Jarom, Smits, Loek P., Bonta, Peter I., van Es, Nick
Publicado 2020

Vascular neutrophilic inflammation and immunothrombosis distinguish severe COVID‐19 from influenza pneumonia

por Nicolai, Leo, Leunig, Alexander, Brambs, Sophia, Kaiser, Rainer, Joppich, Markus, Hoffknecht, Marie‐Louise, Gold, Christoph, Engel, Anouk, Polewka, Vivien, Muenchhoff, Maximilian, Hellmuth, Johannes C., Ruhle, Adrian, Ledderose, Stephan, Weinberger, Tobias, Schulz, Heiko, Scherer, Clemens, Rudelius, Martina, Zoller, Michael, Keppler, Oliver T., Zwißler, Bernhard, von Bergwelt‐Baildon, Michael, Kääb, Stefan, Zimmer, Ralf, Bülow, Roman D., von Stillfried, Saskia, Boor, Peter, Massberg, Steffen, Pekayvaz, Kami, Stark, Konstantin
Publicado 2021

Thromboinflammation in COVID‐19: Can α(2)‐macroglobulin help to control the fire?

por Seitz, Rainer, Gürtler, Lutz, Schramm, Wolfgang
Publicado 2021

Prolonged elevation of D‐dimer levels in convalescent COVID‐19 patients is independent of the acute phase response

por Townsend, Liam, Fogarty, Helen, Dyer, Adam, Martin‐Loeches, Ignacio, Bannan, Ciaran, Nadarajan, Parthiban, Bergin, Colm, O’Farrelly, Cliona, Conlon, Niall, Bourke, Nollaig M., Ward, Soracha E., Byrne, Mary, Ryan, Kevin, O’Connell, Niamh, O’Sullivan, Jamie M., Ni Cheallaigh, Cliona, O’Donnell, James S.
Publicado 2021

COVID‐19 patients often show high‐titer non‐platelet‐activating anti‐PF4/heparin IgG antibodies

por Brodard, Justine, Kremer Hovinga, Johanna A., Fontana, Pierre, Studt, Jan‐Dirk, Gruel, Yves, Greinacher, Andreas
Publicado 2021

ADAMTS13 regulation of VWF multimer distribution in severe COVID‐19

por Ward, Soracha E., Fogarty, Helen, Karampini, Ellie, Lavin, Michelle, Schneppenheim, Sonja, Dittmer, Rita, Morrin, Hannah, Glavey, Siobhan, Ni Cheallaigh, Cliona, Bergin, Colm, Martin‐Loeches, Ignacio, Mallon, Patrick W., Curley, Gerard F., Baker, Ross I., Budde, Ulrich, O’Sullivan, Jamie M., O’Donnell, James S., O’Connell, Niamh, Byrne, Mary, Townsend, Liam, McEvoy, Natalie L., Clarke, Jennifer, Boylan, Maria, Alalqam, Razi, Worrall, Amy P., Kelly, Claire, de Barra, Eoghan, Preston, Roger, Kenny, Dermot
Publicado 2021

An observational study to identify the prevalence of thrombocytopenia and anti‐PF4/polyanion antibodies in Norwegian health care workers after COVID‐19 vaccination

por Sørvoll, Ingvild Hausberg, Horvei, Kjersti Daae, Ernstsen, Siw Leiknes, Lægreid, Ingvild Jenssen, Lund, Svetlana, Grønli, Renathe Henriksen, Olsen, Magnus Kringstad, Jacobsen, Hege Karine, Eriksson, Anna, Halstensen, Anne Marie, Tjønnfjord, Eirik, Ghanima, Waleed, Ahlen, Maria Therese
Publicado 2021

Antibody‐mediated platelet activation in COVID‐19: A coincidence or a new mechanism of the dysregulated coagulation system?

por Althaus, Karina, Zlamal, Jan, Bakchoul, Tamam
Publicado 2021

Persistent endotheliopathy in the pathogenesis of long COVID syndrome

por Fogarty, Helen, Townsend, Liam, Morrin, Hannah, Ahmad, Azaz, Comerford, Claire, Karampini, Ellie, Englert, Hanna, Byrne, Mary, Bergin, Colm, O’Sullivan, Jamie M., Martin‐Loeches, Ignacio, Nadarajan, Parthiban, Bannan, Ciaran, Mallon, Patrick W., Curley, Gerard F., Preston, Roger J.S., Rehill, Aisling M., McGonagle, Dennis, Ni Cheallaigh, Cliona, Baker, Ross I., Renné, Thomas, Ward, Soracha E., O’Donnell, James S., O’Connell, Niamh, Ryan, Kevin, Kenny, Dermot, Fazavana, Judicael
Publicado 2021

Pathogenic lipid‐binding antiphospholipid antibodies are associated with severity of COVID‐19

por Hollerbach, Anne, Müller‐Calleja, Nadine, Pedrosa, Denise, Canisius, Antje, Sprinzl, Martin F., Falter, Tanja, Rossmann, Heidi, Bodenstein, Marc, Werner, Christian, Sagoschen, Ingo, Münzel, Thomas, Schreiner, Oliver, Sivanathan, Visvakanth, Reuter, Michael, Niermann, Johannes, Galle, Peter R., Teyton, Luc, Ruf, Wolfram, Lackner, Karl J.
Publicado 2021

Comparison of adverse drug reactions among four COVID‐19 vaccines in Europe using the EudraVigilance database: Thrombosis at unusual sites

por Abbattista, Maria, Martinelli, Ida, Peyvandi, Flora
Publicado 2021

Remote history of VTE is associated with severe COVID‐19 in middle and older age: UK Biobank cohort study

por Anderson, Jana J., Ho, Frederick K., Niedzwiedz, Claire L., Katikireddi, Srinivasa Vittal, Celis‐Morales, Carlos, Iliodromiti, Stamatina, Welsh, Paul, Pellicori, Pierpaolo, Demou, Evangelia, Hastie, Claire E., Lyall, Donald M., Gray, Stuart R., Forbes, John F., Gill, Jason M.R., Mackay, Daniel F., Berry, Colin, Cleland, John G.F., Sattar, Naveed, Pell, Jill P.
Publicado 2021

The CoVID‐TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID‐19

por Li, Ang, Kuderer, Nicole M., Hsu, Chih‐Yuan, Shyr, Yu, Warner, Jeremy L., Shah, Dimpy P., Kumar, Vaibhav, Shah, Surbhi, Kulkarni, Amit A., Fu, Julie, Gulati, Shuchi, Zon, Rebecca L., Li, Monica, Desai, Aakash, Egan, Pamela C., Bakouny, Ziad, KC, Devendra, Hwang, Clara, Akpan, Imo J., McKay, Rana R., Girard, Jennifer, Schmidt, Andrew L., Halmos, Balazs, Thompson, Michael A., Patel, Jaymin M., Pennell, Nathan A., Peters, Solange, Elshoury, Amro, de Lima Lopes, Gilbero, Stover, Daniel G., Grivas, Petros, Rini, Brian I., Painter, Corrie A., Mishra, Sanjay, Connors, Jean M., Lyman, Gary H., Rosovsky, Rachel P.
Publicado 2021

Vaccine‐induced immune thrombotic thrombocytopenia (VITT): Update on diagnosis and management considering different resources

por Greinacher, Andreas, Langer, Florian, Makris, Mike, Pai, Menaka, Pavord, Sue, Tran, Huyen, Warkentin, Theodore E.
Publicado 2022

Antibody‐mediated procoagulant platelet formation in COVID‐19 is AKT dependent

por Pelzl, Lisann, Singh, Anurag, Funk, Jonas, Witzemann, Andreas, Marini, Irene, Zlamal, Jan, Weich, Karoline, Abou‐Khalel, Wissam, Hammer, Stefanie, Uzun, Guenalp, Althaus, Karina, Bakchoul, Tamam
Publicado 2022

Thrombosis pathways in COVID‐19 vs. influenza‐associated ARDS: A targeted proteomics approach

por Rademaker, Emma, Doorduijn, Dennis J., Kusadasi, Nuray, Maas, Coen, Drylewicz, Julia, Huisman, Albert, Hoefer, Imo E., Bonten, Marc J.M., Derde, Lennie P.G., Rooijakkers, Suzan H.M., Cremer, Olaf L.
Publicado 2022

Platelet size as a mirror for the immune response after SARS‐CoV‐2 vaccination

por Thiele, Thomas, Schwarz, Silas L., Handtke, Stefan
Publicado 2022